Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 5, 2026

10 Magnificent Stocks That Can Make You Richer in 2026

View original at finance.yahoo.com
10 Magnificent Stocks That Can Make You Richer in 2026 Key Points The stock market's major indexes delivered, once again, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all climbing to record highs in 2025…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stock Advisor's total average return is 966%, compared to 194% for the S&P 500

    80% confidence
  • A forward P/E of 11 for an ultrarare-disease company with rapidly expanding operating cash flow is a bargain that investors shouldn't pass up

    80% confidence
  • If Optum's operating margin rebounds to near 7% this year, UnitedHealth stock could easily be one of the Dow's top performers

    80% confidence
  • BioMarin is on track to deliver mid-to-high single-digit sales growth in 2026 and more than $5 in earnings per share

    80% confidence
  • The 10 best stocks for investors to buy now do not include Visa

    80% confidence
  • Voxzogo is on track to likely top $1 billion in full-year sales this year

    80% confidence
  • 10 sensational businesses are ideally positioned to make investors money in 2026

    80% confidence
  • York Water has been paying a dividend for 209 consecutive years

    80% confidence
  • Visa's outperformance reflects its close-knit ties to the U.S. and global economy

    80% confidence
  • The Trade Desk's forward P/E ratio of 18 with mid-to-high teens annual sales growth is a bargain

    80% confidence
  • Meta Platforms is the one member of the Magnificent Seven that remains fundamentally attractive

    80% confidence
  • UnitedHealth's 2025 performance was an anomaly and company is taking steps to ensure turnaround

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
10 Magnificent Stocks That Can Make You Richer in 2026 — Source | Via News | ViaNews Market